Clinical Trial Information
A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease- Protocol Number: 10603
- Status: Open
- Age Group: Adult
- Treatment Type: Treatment
- Secondary Protocol No.: RPC01-3204
- Phase: III
- NCT ID: NCT03467958
Scope Information
- Scope:
- National
- Disease Site(s):
- Other